Target intelligence / Profile preview

Ferrous iron transport protein B (FeoB)

Target
FeoB
Molecular classification
Transporter, Integral membrane protein, GTPase
01

Overview

Ferrous iron transport protein B (FeoB) is an integral membrane protein found in many prokaryotes (bacteria and archaea) and is a principal component of the Feo system, which enables high-affinity uptake of ferrous iron (\( Fe^{2+} \)) under reducing and anaerobic conditions[1][2][3][4][5]. FeoB typically consists of 700–800 amino acids, with an N-terminal cytosolic G-protein (GTPase) domain that regulates transport activity, and a C-terminal membrane domain forming the translocation pore[1][4][5]. The Feo system commonly includes at least two genes, feoA and feoB, sometimes feoC, but FeoB is essential for mediating ferrous iron import[2][3][4][5]. FeoB is vital for maintaining cellular iron homeostasis and is crucial for the virulence and survival of pathogenic bacteria in host environments, particularly where iron is limiting[2][3][4][5]. This protein does not exist in animals or plants, making it a potential target for antimicrobial drug discovery, but there are currently no direct small-molecule inhibitors in therapeutic use[4][5].

Other names
FeoBFerrous iron transporter BIron transport protein FeoBFerrous iron uptake protein B
02

Mechanism of action

N/A for small-molecule drugs (the target is principally inhibited or studied genetically; no approved drugs directly inhibit FeoB) Potential mechanisms: inhibition of iron uptake, occupation of transporter, GTPase inhibition (experimental)

03

Biological functions

Iron uptake/transportMaintenance of intracellular iron homeostasisBacterial survival and virulence (in pathogens)
04

Disease associations

Infection (important for bacterial pathogenesis)Other (iron acquisition systems relevant for survival in host environments)
05

Safety considerations

Targeting FeoB in bacteria could affect essential pathways for iron uptake, impacting bacterial survival; no direct therapeutic safety concerns in humans since FeoB is not present in eukaryotesTherapeutic challenge: selectively inhibiting this transporter in bacteria without affecting beneficial microbiota or provoking resistance

Beyond the preview

Go deeper on Ferrous iron transport protein B (FeoB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferrous iron transport protein B (FeoB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call